Tosh, Jonathan C <br/><br/>
Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis.  [electronic resource] 

 -  The Journal of rheumatology  Aug 2011 
 - 1593-600 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.101327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--economics<br/>Arthritis, Rheumatoid--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Therapy, Combination--economics<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Quality-Adjusted Life Years<br/>Randomized Controlled Trials as Topic<br/>Surveys and Questionnaires<br/>Treatment Outcome